AtriCure, Inc.
ATRC Healthcare Medical Instruments & Supplies
AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024.
- Revenue
- +15.0%
- EPS
- +1,583.9%
- Free cash flow
- −0.73%
- Total debt
- −17.3%
Quarter to September 2026, against a year earlier
Follow ATRC
Alert me
AtriCure, Inc. (ATRC) Revenue growth
AtriCure, Inc.'s revenue growth over the twelve months to 30 September 2026 was 13.8%, down 1.1 percentage points from fiscal 2025 (14.9%). Over the past ten years it has ranged from −10.5% (fiscal 2020) to 32.8% (fiscal 2021); the current reading is higher than 36% of that period. That is above the Medical Instruments & Supplies industry median of 8.97% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 14.9% | (1.67) |
| FY2024 | 16.6% | (4.29) |
| FY2023 | 20.8% | 0.41 |
| FY2022 | 20.4% | (12.40) |
| FY2021 | 32.8% | 43.35 |
| FY2020 | −10.5% | (24.99) |
| FY2019 | 14.5% | (0.93) |
| FY2018 | 15.4% | 2.76 |
| FY2017 | 12.6% | (6.90) |
| FY2016 | 19.5% | (1.21) |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 15.0% | 2.20 |
| Jun 2026 | 12.8% | (1.43) |
| Mar 2026 | 14.3% | 1.21 |
| Dec 2025 | 13.1% | (2.79) |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| PLSE Pulse Biosciences, Inc compare | 90.1% |
| ATRC AtriCure, Inc. | 13.8% |
| STVN Stevanato Group S.p.A. compare | 11.6% |
| WRBY Warby Parker Inc. compare | 9.89% |
| NVST Envista Holdings Corporation compare | 9.78% |
| MMSI Merit Medical Systems, Inc. compare | 9.06% |
| XRAY DENTSPLY SIRONA Inc. compare | −1.35% |
| ICUI ICU Medical, Inc. compare | −5.92% |
| MMED MiniMed Group, Inc. compare | — |
| Medical Instruments & Supplies industry median | 8.97% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on ATRC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement